RBC Capital analyst Sean Dodge maintained a Buy rating on R1 RCM (NASDAQ:RCM) Inc on Friday, setting a price target of $35, which is approximately 25.36% above the present share price of $27.92.
Dodge expects R1 RCM Inc to post earnings per share (EPS) of $0.00 for the first quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in R1 RCM, with an average price target of $28.5.
The analysts price targets range from a high of $35 to a low of $26.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $307.2 million and a net profit of $22.1 million. The company's market cap is $7.27 billion.
According to TipRanks.com, RBC Capital analyst Sean Dodge is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 21.9% and a 65.28% success rate.
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.